Analyze Diet

Topic:Disease Treatment

Disease treatment in horses encompasses a range of medical interventions and management strategies aimed at addressing various health conditions affecting equine species. These treatments can include pharmacological approaches, such as the administration of antibiotics, anti-inflammatory drugs, and antiparasitic medications, as well as non-pharmacological methods like physical therapy, dietary adjustments, and surgical procedures. The selection of appropriate treatments depends on the specific disease, its severity, and the individual needs of the horse. This topic brings together peer-reviewed research studies and scholarly articles that explore the efficacy, safety, and advancements in therapeutic options for equine diseases, providing insights into best practices and emerging trends in equine veterinary medicine.
An update on Sarcocystis neurona infections in animals and equine protozoal myeloencephalitis (EPM).
Veterinary parasitology    February 7, 2015   Volume 209, Issue 1-2 1-42 doi: 10.1016/j.vetpar.2015.01.026
Dubey JP, Howe DK, Furr M, Saville WJ, Marsh AE, Reed SM, Grigg ME.Equine protozoal myeloencephalitis (EPM) is a serious disease of horses, and its management continues to be a challenge for veterinarians. The protozoan Sarcocystis neurona is most commonly associated with EPM. S. neurona has emerged as a common cause of mortality in marine mammals, especially sea otters (Enhydra lutris). EPM-like illness has also been recorded in several other mammals, including domestic dogs and cats. This paper updates S. neurona and EPM information from the last 15 years on the advances regarding life cycle, molecular biology, epidemiology, clinical signs, diagnosis, treat...
Adipose-derived stem cells in veterinary medicine: characterization and therapeutic applications.
Stem cells and development    February 5, 2015   Volume 24, Issue 7 803-813 doi: 10.1089/scd.2014.0407
Marx C, Silveira MD, Beyer Nardi N.Mesenchymal stem cells, considered one of the most promising cell types for therapeutic applications due to their capacity to secrete regenerative bioactive molecules, are present in all tissues. Stem cells derived from the adipose tissue have been increasingly used for cell therapy in humans and animals, both as freshly isolated, stromal vascular fraction (SVF) cells, or as cultivated adipose-derived stem cells (ASCs). ASCs have been characterized in different animal species for proliferation, differentiation potential, immunophenotype, gene expression, and potential for tissue engineering. W...
Statistical guidelines for Equine Veterinary Journal.
Equine veterinary journal    February 4, 2015   Volume 47, Issue 2 131-132 doi: 10.1111/evj.12400
Christley R.No abstract available
Equine herpesvirus-1: dealing practically but effectively with an ever present threat.
Equine veterinary journal    February 4, 2015   Volume 47, Issue 2 142-144 doi: 10.1111/evj.12416
Gonzalez-Medina S, Newton JR.No abstract available
Why clinicians should consider tumour staging and grading in horses.
Equine veterinary journal    February 4, 2015   Volume 47, Issue 2 141 doi: 10.1111/evj.12398
Ensink JM.No abstract available
Changes in the equine fecal microbiota associated with the use of systemic antimicrobial drugs.
BMC veterinary research    February 3, 2015   Volume 11 19 doi: 10.1186/s12917-015-0335-7
The intestinal tract is a rich and complex environment and its microbiota has been shown to have an important role in health and disease in the host. Several factors can cause disruption of the normal intestinal microbiota, including antimicrobial therapy, which is an important cause of diarrhea in horses. This study aimed to characterize changes in the fecal bacterial populations of healthy horses associated with the administration of frequently used antimicrobial drugs. Results: Twenty-four adult mares were assigned to receive procaine penicillin intramuscularly (IM), ceftiofur sodium IM, tr...
Intra-articular treatment with triamcinolone compared with triamcinolone with hyaluronate: A randomised open-label multicentre clinical trial in 80 lame horses.
Equine veterinary journal    February 2, 2015   Volume 48, Issue 2 152-158 doi: 10.1111/evj.12383
de Grauw JC, Visser-Meijer MC, Lashley F, Meeus P, van Weeren PR.Intra-articular (IA) injection of corticosteroids with or without hyaluronate (HA) has been used for decades in equine practice for treatment of noninfectious synovitis and osteoarthritis. However, to date, no large-scale randomised equine field trials have been reported that address the supposed superior clinical efficacy of the combination of corticosteroid + HA compared with IA injection of corticosteroid alone. Objective: To compare the clinical efficacy of IA triamcinolone acetonide (TA, 12 mg) compared with IA TA (12 mg) + high molecular weight HA (20 mg) in horses with clinical jo...
A comparison of seven methods for continuous therapeutic cooling of the equine digit.
Equine veterinary journal    February 2, 2015   Volume 48, Issue 1 120-124 doi: 10.1111/evj.12384
van Eps AW, Orsini JA.Digital hypothermia may be effective for laminitis prophylaxis and therapy, but the efficacy of cooling methods used in clinical practice requires evaluation. Objective: To use hoof wall surface temperature (HWST) to compare several cooling methods used in clinical practice. Methods: Experimental crossover design with a minimum washout period of 72 h. Methods: Seven cooling methods (commercially available ice packs, wraps and boots) and one prototypical dry-sleeve device were applied to a single forelimb in 4 horses for 8 h, during which HWST of the cooled forelimb and the uncooled (contro...
Colostrum hexasaccharide, a novel Staphylococcus aureus quorum-sensing inhibitor.
Antimicrobial agents and chemotherapy    February 2, 2015   Volume 59, Issue 4 2169-2178 doi: 10.1128/AAC.03722-14
Srivastava A, Singh BN, Deepak D, Rawat AK, Singh BR.The discovery of quorum-sensing (QS) systems regulating antibiotic resistance and virulence factors (VFs) has afforded a novel opportunity to prevent bacterial pathogenicity. Dietary molecules have been demonstrated to attenuate QS circuits of bacteria. But, to our knowledge, no study exploring the potential of colostrum hexasaccharide (CHS) in regulating QS systems has been published. In this study, we analyzed CHS for inhibiting QS signaling in Staphylococcus aureus. We isolated and characterized CHS from mare colostrum by high-performance thin-layer chromatography (HPTLC), reverse-phase hig...
Intrafollicular treatment with prostaglandins PGE2 and PGF2α inhibits the formation of luteinised unruptured follicles and restores normal ovulation in mares treated with flunixin-meglumine.
Equine veterinary journal    February 2, 2015   Volume 48, Issue 2 211-217 doi: 10.1111/evj.12396
Martínez-Boví R, Cuervo-Arango J.Haemorrhagic anovulatory follicle is the most common pathological anovulatory condition in the mare, but its cause remains unknown. An experimental model to induce luteinised unruptured follicles (LUF) with flunixin-meglumine (FM) has been developed. Luteinised unruptured follicles share similar morphological and hormonal characteristics with haemorrhagic anovulatory follicles. Objective: To test the effect of intrafollicular administration of prostaglandins PGE2 and PGF2α during the periovulatory period on ovulation and pregnancy in FM-treated mares. Methods: In vivo experiment in a crossove...
Horizontal-guided Bone Regeneration using a Titanium Mesh and an Equine Bone Graft.
The journal of contemporary dental practice    February 1, 2015   Volume 16, Issue 2 154-162 doi: 10.5005/jp-journals-10024-1653
Di Stefano DA, Greco GB, Cinci L, Pieri L.The present work describes a horizontal ridge augmentation in which a titanium mesh was preshaped by adapting it to a stereolithographic model of the patient's jaw that was fabricated from CT scans. Guided bone regeneration (GBR) involves covering the augmentation site with a long-lasting barrier to protect it from the invasion of surrounding soft tissues. Among barriers, titanium meshes may provide a successful outcome, but the intraoperatory time needed to shape them is a disadvantage. The 54-year-old patient, missing the right mandibular second bicuspid, first molar, and second molar, had h...
Le virus de l’artérite virale équine : de l’épidémiologie moléculaire à l’émergence de variants pathogènes.
Virologie (Montrouge, France)    February 1, 2015   Volume 19, Issue 1 7-18 doi: 10.1684/vir.2015.0588
Miszczak F, Pronost S, Vabret A.Equine arteritis virus (EAV) is the causative agent of equine viral arteritis, a disease observed only in equids. EAV is the prototype of the family Arteriviridæ within the order Nidovirales. EAV is an enveloped, positive-sense, single-stranded RNA virus with a considerable variation in the genome as observed in other RNA viruses. During natural infections, EAV may cause abortion and persistent subclinical infections in stallions which can shed the virus in the semen for years, or even lifetime. Chronically infected stallions represent the natural reservoir of the virus. They ensure the persi...
Update on viral diseases of the equine respiratory tract.
The Veterinary clinics of North America. Equine practice    January 31, 2015   Volume 31, Issue 1 91-104 doi: 10.1016/j.cveq.2014.11.007
Gilkerson JR, Bailey KE, Diaz-Méndez A, Hartley CA.Many viral agents have been associated with respiratory disease of the horse. The most important viral causes of respiratory disease in horses are equine influenza and the equine alphaherpesviruses. Agents such as equine viral arteritis virus, African horse sickness virus, and Hendra virus establish systemic infections. Clinical signs of disease resulting from infection with these agents can manifest as respiratory disease, but the respiratory tract is not the major body system affected by these viruses. Treatment of viral respiratory disease is generally limited to supportive therapies, where...
Regional intravenous limb perfusion compared to systemic intravenous administration for marimastat delivery to equine lamellar tissue.
Journal of veterinary pharmacology and therapeutics    January 30, 2015   Volume 38, Issue 4 392-399 doi: 10.1111/jvp.12198
Underwood C, Collins SN, Mills PC, Van Eps AW, Allavena RE, Medina Torres CE, Pollitt CC.Pharmaceutical agents with potential for laminitis prevention have been identified. Many of these, including the MMP inhibitor marimastat, are impractical for systemic administration. This study compared local delivery of marimastat by regional limb perfusion (RLP) to systemic intravenous bolus dosing (SIVB), and established whether RLP results in local lamellar drug delivery. Six adult horses received 0.23 mg/kg of marimastat by RLP followed by 0.23 mg/kg marimastat by SIVB, with a 24-h washout period. Lamellar ultrafiltration probes sampled lamellar interstitial fluid as lamellar ultrafiltra...
Characterization of endothelial colony-forming cells from peripheral blood samples of adult horses.
American journal of veterinary research    January 30, 2015   Volume 76, Issue 2 174-187 doi: 10.2460/ajvr.76.2.174
Salter MM, Seeto WJ, DeWitt BB, Hashimi SA, Schwartz DD, Lipke EA, Wooldridge AA.To isolate and characterize endothelial colony-forming cells (ECFCs; a subtype of endothelial progenitor cells) from peripheral blood samples of horses. Methods: Jugular venous blood samples from 24 adult horses. Methods: Blood samples were cultured in endothelial cell growth medium. Isolated ECFCs were characterized by use of functional assays of fluorescence-labeled acetylated low-density lipoprotein (DiI-Ac-LDL) uptake and vascular tubule formation in vitro. Expression of endothelial (CD34, CD105, vascular endothelial growth factor receptor 2, and von Willebrand factor) and hematopoietic (C...
[Interbody fusion procedures. Development from a historical perspective].
Der Orthopade    January 30, 2015   Volume 44, Issue 2 104-113 doi: 10.1007/s00132-015-3076-1
Rickert M, Rauschmann M, Fleege C, Behrbalk E, Harms J.The development of interbody fusion now stretches over many decades and is still not complete. Conclusions: Due to the lack of appropriate implants, the initial fusions were performed via decortication of the dorsal and lateral structures of the spine, followed by placement of an autograft. Despite acceptable fusion results, better primary stability and higher fusion rates were desired. In addition, it became known that the primary load-bearing of the spine is located ventrally in the area of the corpus of the vertebrae. These considerations led to the development of the PLIF technique that wa...
Antiserum from mice vaccinated with modified vaccinia Ankara virus expressing African horse sickness virus (AHSV) VP2 provides protection when it is administered 48h before, or 48h after challenge.
Antiviral research    January 30, 2015   Volume 116 27-33 doi: 10.1016/j.antiviral.2015.01.009
Calvo-Pinilla E, de la Poza F, Gubbins S, Mertens PP, Ortego J, Castillo-Olivares J.Previous studies show that a recombinant modified vaccinia Ankara (MVA) virus expressing VP2 of AHSV serotype 4 (MVA-VP2) induced virus neutralising antibodies in horses and protected interferon alpha receptor gene knock-out mice (IFNAR -/-) against challenge. Follow up experiments indicated that passive transfer of antiserum, from MVA-VP2 immune donors to recipient mice 1h before challenge, conferred complete clinical protection and significantly reduced viraemia. These studies have been extended to determine the protective effect of MVA-VP2 vaccine-induced antiserum, when administered 48h be...
Pharmacokinetics of pergolide after intravenous administration to horses.
American journal of veterinary research    January 30, 2015   Volume 76, Issue 2 155-160 doi: 10.2460/ajvr.76.2.155
Rendle DI, Hughes KJ, Doran GS, Edwards SH.To determine the pharmacokinetics of pergolide after IV administration to horses. Methods: 8 healthy adult horses. Methods: Pergolide mesylate was administered IV at a dose of 20 μg/kg (equivalent to 15.2 μg of pergolide/kg) to each horse, and blood samples were collected over 48 hours. Pergolide concentrations in plasma were determined by means of high-performance liquid chromatography-tandem mass spectrometry, and pharmacokinetic parameters were determined on the basis of noncompartmental methods. Results: After IV administration of pergolide, mean ± SD clearance, elimination half-life, a...
Outbreak of henipavirus infection, Philippines, 2014.
Emerging infectious diseases    January 28, 2015   Volume 21, Issue 2 328-331 doi: 10.3201/eid2102.141433
Ching PK, de los Reyes VC, Sucaldito MN, Tayag E, Columna-Vingno AB, Malbas FF, Bolo GC, Sejvar JJ, Eagles D, Playford G, Dueger E, Kaku Y....During 2014, henipavirus infection caused severe illness among humans and horses in southern Philippines; fatality rates among humans were high. Horse-to-human and human-to-human transmission occurred. The most likely source of horse infection was fruit bats. Ongoing surveillance is needed for rapid diagnosis, risk factor investigation, control measure implementation, and further virus characterization.
Serum thymidine kinase activity in clinically healthy and diseased horses: a potential marker for lymphoma.
Veterinary journal (London, England : 1997)    January 28, 2015   Volume 205, Issue 2 313-316 doi: 10.1016/j.tvjl.2015.01.019
Larsdotter S, Nostell K, von Euler H.Serum thymidine kinase (sTK) activity is a tumour marker used as a prognostic indicator for lymphoma in humans, dogs and cats. The aim of this study was to evaluate the clinical utility of sTK as a biomarker for lymphoma in horses. Serum samples were collected from clinically normal horses (n = 37), horses with lymphoma (n = 23), horses with non-haematopoietic neoplasia (n = 9) and horses with inflammatory disease (n = 14). sTK was measured using a radioenzyme assay. A reference cut-off value of <2.7 U/L (mean + 2 standard deviations, SDs) was established using data fro...
Trends in antimicrobial resistance in equine bacterial isolates: 1999-2012.
The Veterinary record    January 27, 2015   Volume 176, Issue 13 334 doi: 10.1136/vr.102708
Johns IC, Adams EL.This study aimed to identify changing antimicrobial resistance patterns in isolates commonly obtained from equine clinical submissions. Laboratory records from 1999 to 2012 were searched for equine samples from which Escherichia coli or Streptococcus species was isolated. Susceptibility to enrofloxacin, ceftiofur, gentamicin, penicillin G, trimethoprim sulfamethoxazole (TMPS) and tetracyclines was noted. Isolates were divided into those identified between 1999 and 2004 (Early) and between 2007 and 2012 (Late). The proportion of isolates resistant to each antimicrobial and multiple drug-resista...
Efficacy of gamithromycin for the treatment of foals with mild to moderate bronchopneumonia.
Journal of veterinary internal medicine    January 27, 2015   Volume 29, Issue 1 333-338 doi: 10.1111/jvim.12504
Hildebrand F, Venner M, Giguère S.Gamithromycin is active in vitro against the bacterial agents most commonly associated with bronchopneumonia in older foals. However, the clinical efficacy and safety of this drug have not been investigated. Objective: Gamithromycin is effective for the treatment of bronchopneumonia in foals. Methods: One hundred and twenty-one foals on a farm endemic for infections caused by Rhodococcus equi. Methods: In a controlled, randomized, and double blinded clinical trial, foals with ultrasonographic evidence of pulmonary abscesses (abscess score 8.0-20 cm) were randomly allocated in 3 treatment group...
Nanoparticulate CpG immunotherapy in RAO-affected horses: phase I and IIa study.
Journal of veterinary internal medicine    January 27, 2015   Volume 29, Issue 1 286-293 doi: 10.1111/jvim.12524
Klier J, Lehmann B, Fuchs S, Reese S, Hirschmann A, Coester C, Winter G, Gehlen H.Recurrent airway obstruction (RAO), an asthma-like disease, is 1 of the most common allergic diseases in horses in the northern hemisphere. Hypersensitivity reactions to environmental antigens cause an allergic inflammatory response in the equine airways. Cytosine-phosphate-guanosine-oligodeoxynucleotides (CpG-ODN) are known to direct the immune system toward a Th1-pathway, and away from the pro-allergic Th2-line (Th2/Th1-shift). Gelatin nanoparticles (GNPs) are biocompatible and biodegradable immunological inert drug delivery systems that protect CpG-ODN against nuclease degeneration. Prelimi...
Efficacy of liposomal gentamicin against Rhodococcus equi in a mouse infection model and colocalization with R. equi in equine alveolar macrophages.
Veterinary microbiology    January 27, 2015   Volume 176, Issue 3-4 292-300 doi: 10.1016/j.vetmic.2015.01.015
Burton AJ, Giguère S, Berghaus LJ, Hondalus MK, Arnold RD.Rhodococcus equi, a facultative intracellular pathogen and an important cause of pneumonia in foals, is highly susceptible to killing by gentamicin in vitro. However, gentamicin is not effective in vivo, due to its poor cellular penetration. Encapsulation of drugs in liposomes enhances cellular uptake. The objectives of this study were to compare liposomal gentamicin and free gentamicin with respect to their uptake by equine macrophages and intracellular colocalization with R. equi and to compare the efficacies of liposomal gentamicin, free gentamicin and clarithromycin with rifampin for the r...
Cardiac troponin I as compared to troponin T for the detection of myocardial damage in horses.
Journal of veterinary internal medicine    January 27, 2015   Volume 29, Issue 1 348-354 doi: 10.1111/jvim.12530
Van Der Vekens N, Decloedt A, Ven S, De Clercq D, van Loon G.Different cardiac troponin I (cTnI) assays give different results. Only 1 manufacturer has marketed troponin T (cTnT) assays. Therefore, cTnT often is preferred for detection of myocardial infarction in human patients. Studies of cTnT in horses are limited. Objective: To compare a cTnI and a high-sensitive cTnT assay (hs-cTnT) in horses. Methods: Cardiac troponin I and cTnT were determined in 35 healthy horses (group 1), 23 horses suspected to have primary myocardial damage (group 2a), and 41 horses with secondary myocardial damage caused by structural heart disease (group 2b). Methods: All cT...
Equine bone marrow volume reduction, red blood cell depletion, and mononuclear cell recovery using the PrepaCyte-CB processing system.
Veterinary clinical pathology    January 27, 2015   Volume 44, Issue 2 188-193 doi: 10.1111/vcp.12236
Burton AG, Clark KC, Borjesson DL, Carrade DD, Burges J, Owens SD.Volume reduction and RBC depletion of equine bone marrow specimens are necessary processing steps for the immediate therapeutic use of bone marrow (BM)-derived mesenchymal stem cells (MSC), and for MSC expansion in culture. Objective: The purpose of the study was to evaluate the ability of the PrepaCyte-CB processing system to reduce volume, deplete RBC, and recover mononuclear cells (MNC) from equine BM specimens. Methods: One hundred and twenty mL of heparinized BM were obtained from each of 90 horses. A CBC was performed on the BM pre- and post-PrepaCyte-CB processing. Volume and RBC reduct...
Update on fungal respiratory disease in horses.
The Veterinary clinics of North America. Equine practice    January 22, 2015   Volume 31, Issue 1 43-62 doi: 10.1016/j.cveq.2014.11.005
Stewart AJ, Cuming RS.Fungal respiratory disease is a rare occurrence in horses. Fungal organisms are ubiquitous in the equine environment; however, there is a geographic predisposition for disease development, with fungal respiratory infections seen more commonly by practitioners working in tropical or subtropical environments. Diagnosis and treatment of fungal respiratory infections pose a challenge for the equine practitioner, and the prognosis for complete resolution of infection is often guarded; however, new antifungal medications are likely to improve treatment success. This article summarizes the available ...
Laminitis in the 21st century.
The Veterinary record    January 20, 2015   Volume 176, Issue 3 70-71 doi: 10.1136/vr.h53
Wells-Smith L.No abstract available
Theileria equi isolates vary in susceptibility to imidocarb dipropionate but demonstrate uniform in vitro susceptibility to a bumped kinase inhibitor.
Parasites & vectors    January 20, 2015   Volume 8 33 doi: 10.1186/s13071-014-0611-6
Hines SA, Ramsay JD, Kappmeyer LS, Lau AO, Ojo KK, Van Voorhis WC, Knowles DP, Mealey RH.The apicomplexan hemoparasite Theileria equi is a causative agent of equine piroplasmosis, eradicated from the United States in 1988. However, recent outbreaks have sparked renewed interest in treatment options for infected horses. Imidocarb dipropionate is the current drug of choice, however variation in clinical response to therapy has been observed. Methods: We quantified the in vitro susceptibility of two T. equi isolates and a lab generated variant to both imidocarb dipropionate and a bumped kinase inhibitor compound 1294. We also evaluated the capacity of in vitro imidocarb dipropionate ...
Biology of Trypanosoma (Trypanozoon) evansi in experimental heterologous mammalian hosts.
Journal of parasitic diseases : official organ of the Indian Society for Parasitology    January 20, 2015   Volume 40, Issue 3 1047-1061 doi: 10.1007/s12639-014-0633-1
Misra KK, Roy S, Choudhury A.Trypanosoma (Trypanozoon) evansi is a causative agent of the dreadful mammalian disease trypanosomiasis or 'Surra' and carried as a latent parasite in domestic cattle but occasionally proves fatal when transmitted to horses and camel. Sporadic outbreak of 'Surra' to different animals (beside their natural hosts) reminds that T. evansi may be zoonotic, as their close relative cause sleeping sickness to human being. This haemoflagellate is mechanically transmitted by horse fly and its effect on different host varies depending on certain factors including the effectiveness of transmission by mech...